A phase I QTc study of tivozanib in patients with advanced solid tumors.

被引：0
|
作者：
Chadha, Manpreet Kaur
Infante, Jeffrey R.
Cotreau, Monette M.
Jacobson, Lindsey
Strahs, Andrew Louis
Slichenmyer, William
Vargo, Dennis
Moore, Kathleen N.
机构：
[1] Virginia G Piper Canc Ctr, Scottsdale, AZ USA
[2] TGen, Scottsdale, AZ USA
[3] Sarah Cannon Canc Ctr, Nashville, TN USA
[4] AVEO Pharmaceut, Cambridge, MA USA
[5] Stephenson Oklahoma Canc Ctr, Oklahoma City, OK USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 05期
关键词：
D O I：
10.1200/jco.2012.30.5_suppl.445
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
445
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors.
    Rangwala, Fatima A.
    Bendell, Johanna C.
    Kozloff, Mark
    Arrowood, Christy
    Meadows, Jennifer
    Tourt-Uhlig, Sandra Ellen
    Murphy, Jennifer
    Meadows, Kellen
    Morse, Michael
    Uronis, Hope Elizabeth
    Hsu, Shiaowen David
    Zafar, Yousuf
    Hurwitz, Herbert
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [32] A phase I study of pazopanib with weekly paclitaxel and carboplatin in advanced solid tumors.
    Chan, Nancy
    Portal, Daniella E.
    Moss, Rebecca Anne
    Silk, Ann W.
    Stein, Mark N.
    Aisner, Joseph
    Malhotra, Jyoti
    Shih, Weichung
    Lin, Hongxia
    Kane, Michael P.
    Mehnert, Janice M.
    Tan, Antoinette R.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [33] A phase I study of ixabepilone combined with dasatinib in patients with solid tumors.
    Kaiser, C. C.
    Perry, D. J.
    Zimmer, A. S.
    Patterson, J. W.
    Swain, S. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [34] A phase I study of intravenous artesunate (IV AS) in patients with solid tumors.
    Deeken, John F.
    Wang, Hongkun
    Smaglo, Brandon George
    Hwang, Jimmy J.
    He, Aiwu Ruth
    Weiner, Louis M.
    Marshall, John
    Giaccone, Giuseppe
    Liu, Stephen V.
    Luecht, Jim
    Urso, Christina
    Spiegel, Jay Y.
    Cheema, Amrita
    Pishvaian, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [35] A phase I dose escalation and pharmacodynamic study of weekly administered AlbuleukinTM in patients with advanced solid tumors.
    Agarwala, SS
    Bukowski, RM
    Kirkwood, J
    Weiss, P
    Olencki, T
    Grzegorewski, KJ
    Melder, R
    Fox, RA
    Herpst, JM
    Gallant, G
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6230S - 6231S
  • [36] Phase I pharmacokinetic (PK) study of daily imatinib in combination with docetaxel for patients with advanced solid tumors.
    Chatta, GS
    Fakih, M
    Ramalingam, S
    Belani, CP
    Ramanathan, RK
    Zamboni, N
    Friedland, D
    Lis, D
    Tutchko, S
    Egorin, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 138S - 138S
  • [37] A phase I study of MK-2206 in combination with lapatinib in patients (pts) with advanced solid tumors.
    Wisinski, Kari Braun
    Tevaarwerk, Amye
    Bell, Maria
    Burkard, Mark E.
    Eickhoff, Jens C.
    Wilding, George
    LoConte, Noelle K.
    Traynor, Anne M.
    Hoang, Tien
    Heideman, Jennifer
    Kolesar, Jill
    Liu, Glenn
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [38] A phase I study of a novel IAP inhibitor APG-1387 in patients with advanced solid tumors.
    Xu, Ruihua
    Li, Yuhong
    Ji, Jiao
    Qiu, Miaozhen
    Zhang, Yang
    Liu, Wenqin
    Tian, Xiaohong
    Li, Su
    Wang, Hengbang
    Wang, Fenghua
    Zhang, Dongsheng
    Wang, Feng
    Wang, Zhiqiang
    Luo, Huiyan
    Zou, Benyan
    Wang, De shen
    Ren, Chao
    Jin, Ying
    Zhai, Yifan
    Yang, Dajun
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [39] A phase I open label study evaluating VT1021 in patients with advanced solid tumors.
    Cieslewicz, Michael
    Mahalingam, Devalingam
    Harb, Wael A.
    Patnaik, Amita
    Liu, Joyce F.
    Juric, Dejan
    Bullock, Andrea J.
    Zheng, Lei
    Moore, Kathleen N.
    Patel, Manish R.
    Guttendorf, Robert
    Wang, Suming
    Kerstein, Kathy
    Berk, Gregory Ivan
    Watnick, Jing
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [40] A phase I study of safety and pharmacokinetics of NanoBB-1-Dox in patients with advanced solid tumors.
    Filon, Olga
    Krivorotko, Petr
    Kobyakov, Grigory
    Razjivina, Viktoria
    Maximenko, Olga
    Gelperina, Svetlana
    Kreuter, Joerg
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345